Page last updated: 2024-12-11

5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol: InChIKey JWUOZHTYFQHGAB-UHFFFAOYSA-N [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918819
CHEMBL ID496903
SCHEMBL ID113806
MeSH IDM0491253

Synonyms (19)

Synonym
var-10200
hla-20
CHEMBL496903
8-quinolinol, 5-[[4-(2-propynyl)-1-piperazinyl]methyl]-
686722-53-2
5-(4-propargylpiperazin-1-ylmethyl)-8-hydroxy-quinoline
hla20
5-(4-propargylpiperazin-1-ylmethyl)-8-hydroxyquinoline
JWUOZHTYFQHGAB-UHFFFAOYSA-N
SCHEMBL113806
unii-2jh24kl4zg
hla20 compound
5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol
2jh24kl4zg ,
8-quinolinol, 5-((4-(2-propyn-1-yl)-1-piperazinyl)methyl)-
DTXSID10218816
5-[4-propargylpiperazin-1-ylmethyl]-8-hydroxyquinoline
5-((4-(prop-2-yn-1-yl)piperazin-1-yl)methyl)quinolin-8-ol
Q27254831
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID397013Cytotoxicity against human SH-SY5Y cells assessed as decrease in cell viability at 25 uM after 48 hrs by MTT assay relative to control2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
AID396869Cytotoxicity against human SH-SY5Y cells assessed as cell viability at 1 uM after 48 hrs by MTT assay relative to control2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
AID396944Cytotoxicity against human SH-SY5Y cells assessed as decrease in cell viability at 10 uM after 48 hrs by MTT assay relative to control2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
AID397014Cytotoxicity against human SH-SY5Y cells assessed as decrease in cell viability at 50 uM after 48 hrs by MTT assay relative to control2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.95 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (30.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (70.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]